Recovery from a variegate porphyria by a liver transplantation

Liver Transplantation

Volumn 10, Issue 7, 2004, Pages 935-938

  Stojeba, Nathalie ^a   Meyer, Carole ^a   Jeanpierre, Catherine ^a   Perrot, Frédéric ^a   Hirth, Christine ^b   Pottecher, Thierry ^a   Deybach, Jean Charles ^c  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c Louis Mourrier University Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTRIAXONE; FUROSEMIDE; HEME; METHYLPREDNISOLONE; MORPHINE; PORPHOBILINOGEN; PROTOPORPHYRINOGEN OXIDASE; TACROLIMUS; VANCOMYCIN;

ADULT; ALCOHOL ABUSE; ALCOHOL LIVER CIRRHOSIS; ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; CONVALESCENCE; FECES ANALYSIS; GRAFT REJECTION; HEME SYNTHESIS; HUMAN; LABORATORY TEST; LIVER TRANSPLANTATION; MALE; OUTCOMES RESEARCH; PERIOPERATIVE PERIOD; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORPHYRIA, VARIEGATE; TREATMENT OUTCOME;

EID: 3242809783     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20136     Document Type: Article

References (27)

1. Deybach JC, Puy H, Nordmann Y. Porphyries hépatiques et médicaments. Gastroenterol Clin Biol 1994;18:348-353.
2. Bloomer JR. The hepatic porphyrias. Pathogenesis, manifestations, and management. Gastroenterology 1976;71:689-701.
3. Frank J, Christiano AM. Variegate porphyria: Past, present and future. Skin Pharmacol Appl Skin Physiol 1998;11:310-320.
4. Puy H, Robreau AM, Rosipal R, Nordman Y, Deybach JC. Protoporphyrinogen oxidase: Complete genomic sequence and polymorphisms in the human gene. Biochem Biophys Res Commun 1996;9:226-230.
5. Kirsch RE, Meissner PN, Hift RJ. Variegate porphyria. Semin Liver Dis 1998;18:33-41.
6. Blanloeil Y. Porphyries h' ; patiques aiguës et Diprivan. Ann Fr Anesth Reanim 1994;13:485-489.
7. Meissner PN, Harrison GG, Hift RJ. Propofol as an i.v anaesthetic induction agent in variegate porphyria. Br J Anaesth 1991; 66:60-65.
8. Tidmarsch MD. Porphyria, propofol and rats. Br J Anaesth 1996;76:171-172.
9. Asirvatham SJ, Johnson TW, Oberoi MP, Jackman WN. Prolonged loss of consciousness and elevated porphyrins following propofol administrations. Anesthesiology 1998;89:1029-31.
10. Sarantopoulos CD, Bratanow NC, Stowe DF, Kampine JP. Uneventful propofol anesthesia in a patient with coexisting hereditary coproporphyria and hereditary angioneurotic edema. Anesthesiology 2000;92:607-609.
11. Elcock D, Norris A. Elevated porphyrins following propofol anesthesia in acute intermittent porphyria. Anesthesia 1994;49: 957-958.
12. Jensen NF, Fiddler DS, Striepe V. Anesthetic considerations in porphyrias. Anesth Analg 1995;80:591-599.
13. Ashley EM. Anaesthesia for porphyria. Br J Hosp Med 1996;56: 37-42.
14. Harrison GG, Meissner PN, Hift RJ. Anaesthesia for the porphyric patient. Anaesthesia 1993;48:417-421.
15. James MFM, Hift RJ. Porphyrias. Br J Anaesth 2000;85:143-153.
16. Evans PR, Graham S, Kumar CM. The use of sevoflurane in acute intermittent porphyria. Anaesthesia 2001;56:388-389.
17. Famewo CE. Induction of anaesthesia with etomidate in a patient with acute intermittent porphyria. Can Anaesth Soc J 1985;32:171-32173.
18. Capouet V, Dernovoi B, Azagra JS. Induction of anesthesia with ketamine during an acute crisis of hereditary coproporphyria. Can J Anaesth 1987;34:388-390.
19. Durmus M, Turkoz A, Togal T, Koroglu A, Toprak HI, Ersoy MO. Remifentanil and acute intermittent porphyria. Eur J Anaesthesiol 2002;19:839-840.
20. Böhrer H, Schmidt H, Bach A, Martin E, Kohl B, Bolsen K, et al. Porphyrinogenic effects of atracurium, vecuronium and pancuronium in a primed rat model. Lab Anim Sci 1994;44:326-330.
21. Lin YC, Chen L. Atracurium in a patient with acute intermittent porphyria. Anesth Analg 1990;71:440-441.
22. Sneyd JR, Kreimer-Birbbaum M, Lust MR, Heflin J. Use of sufentanil and atracurium anesthesia in a patient with acute porphyria undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1995;9:75-78.
23. Nunez DJ, Williams PF, Herrick AL, Evans DB, McColl KE. Renal transplantation for the chronic renal failure in acute porphyria. Nephrol Dial Transplant 1987;2:271-274.
24. Brunner LJ, Bennett WM, Koop DR. Cyclosporine suppresses rat hepatic cytochrome P450 in a time-dependant manner. Kidney Int 1998;54:216-223.
25. Moore MR, Hift RJ. Drugs in the acute porphyrias - toxicogenetic diseases. Cell Mol Biol 1997;43:89-94.
26. Barone GW, Gurley BJ, Anderson KE, Ketel BL, Abul-Ezz SR. The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria. J Clin Pharmacol 2001;41:113-115.
27. Leone N, Marzano A, Cerutti E, Actis GC, Marchesa PE, David E, et al. Liver transplantation for erythropoietic protoporphyria: Report of a case with medium-term follow-up. Dig Liver Dis 2000;32:799-802.